Correlation Between Pharmadrug and BellRock Brands
Can any of the company-specific risk be diversified away by investing in both Pharmadrug and BellRock Brands at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmadrug and BellRock Brands into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmadrug and BellRock Brands, you can compare the effects of market volatilities on Pharmadrug and BellRock Brands and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmadrug with a short position of BellRock Brands. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmadrug and BellRock Brands.
Diversification Opportunities for Pharmadrug and BellRock Brands
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pharmadrug and BellRock is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmadrug and BellRock Brands in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BellRock Brands and Pharmadrug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmadrug are associated (or correlated) with BellRock Brands. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BellRock Brands has no effect on the direction of Pharmadrug i.e., Pharmadrug and BellRock Brands go up and down completely randomly.
Pair Corralation between Pharmadrug and BellRock Brands
If you would invest 1.51 in Pharmadrug on September 12, 2024 and sell it today you would lose (0.49) from holding Pharmadrug or give up 32.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pharmadrug vs. BellRock Brands
Performance |
Timeline |
Pharmadrug |
BellRock Brands |
Pharmadrug and BellRock Brands Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharmadrug and BellRock Brands
The main advantage of trading using opposite Pharmadrug and BellRock Brands positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmadrug position performs unexpectedly, BellRock Brands can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BellRock Brands will offset losses from the drop in BellRock Brands' long position.Pharmadrug vs. 4Front Ventures Corp | Pharmadrug vs. Khiron Life Sciences | Pharmadrug vs. BellRock Brands | Pharmadrug vs. Elixinol Global |
BellRock Brands vs. THC Therapeutics | BellRock Brands vs. Elixinol Global | BellRock Brands vs. Eisai Co | BellRock Brands vs. Mc Endvrs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |